Showing 5281-5290 of 7669 results for "".
Are We Overlooking Skin Cancer in Ethnic Minorities?
https://practicaldermatology.com/issues/supplements/are-we-overlooking-skin-cancer-in-ethnic-minorities/21718/Skin cancers in Hispanic and African American patients may be detected at more advanced stages, leading to poorer prognoses and long-term outcomes compared to non-Hispanic whites.Noah Worcester 2024: Dr. Bridges on Practice Management
https://practicaldermatology.com/conferences/noah-worcester-2024/noah-worcester-2024-dr-bridges-practice-management/24580/Alina Bridges, DO, FAAD, summarizes her lecture on practice management and coding at the 2024 Noah Worcester Dermatological Society meeting.Shifting Paradigms on Lentigo Maligna
https://practicaldermatology.com/programs/practical-dermatology-skin-cancer/shifting-paradigms-on-lentigo-maligna/20255/According to Ashfaq Marghoob, MD, current research supports individualizing treatment of lentigo maligna (LM) based on what is the best therapeutic option, from active surveillance to surgery to radiation to imiquimod.The Microbiome in Atopic Dermatitis: Where Are We Now?
https://practicaldermatology.com/topics/atopic-dermatitis/the-microbiome-in-atopic-dermatitis-where-are-we-now/23746/It seems increasingly likely that microbes will play a central role in understanding AD and its treatments.Scientifically Speaking: Sunscreen Update from Terri Michele, MD of the FDA CDER
https://practicaldermatology.com/topics/skin-cancer-photoprotection/scientifically-speaking-sunscreen-update-from-terri-michele-md-of-the-fda-cder/19853/What is the latest on sunscreen labeling? What are implications of recent serology studies? And could new screening agents come to the US market? Host Joel L. Cohen, MD talks to Terri Michele, MD, Director of the Office of Nonprescription Drugs in FDA CDER about these and other hot topics in sun proDERM2020 Attendee Reaction: TJ Chao, MPAS, PA-C
https://practicaldermatology.com/conferences/dermatology-education-foundation-derm-2020/derm2020-attendee-reaction-tj-chao-mpas-pa-c/19846/TJ Chao, MPAS, PA-C from Atlanta, GA shares his thoughts on participating in DERM2020.Advances in Understanding the Skin’s Microbiome
https://practicaldermatology.com/series/dermatology-dispatches/advances-in-understanding-the-skins-microbiome/19772/A growing body of evidence suggests that cutaneous dysbiosis plays a role in atopic dermatitis, psoriasis, acne, and rosacea, explains Adam Friedman, MD. Efforts to encourage diversity in the skin’s microbiome with pre- and probiotics may change the way dermatologists treat these diseases in the futGene Expression Profile Testing in the Management of Malignant Melanoma
https://practicaldermatology.com/topics/skin-cancer-photoprotection/gene-expression-profile-testing-in-the-management-ofmalignant-melanoma/23030/A test analyzes 31 specific genes in excised tumors to predict risk for metastasis.Perspective: The ABD's Push for Subspecialty Certification in Mohs Surgery Will Fracture Dermatology
https://practicaldermatology.com/topics/skin-cancer-photoprotection/perspective-the-abds-push-for-subspecialty-certification-in-mohs-surgery-will-fracture-dermatology/20502/Will SC infringe on the rights of non-certified dermatologists to preform Mohs? Could it lead to reduced exposure to this and other surgical treatments for future dermatologists in training?Physician Spotlight: Desiree Ratner, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-desiree-ratner-md/20505/Winning the war on non-melanoma skin cancer.